Kathleen Sereda Glaub

About

Kathleen Sereda Glaub is a biotech executive and board director with more than 30 years of experience in corporate development, financing, and company-building. She is co-founder and chief executive officer of CuraSen Therapeutics, previously served as chief executive officer of Afferent Pharmaceuticals through its sale to Merck, and earlier spent 12 years as president of Plexxikon. She also serves on public-company and private-company boards including IO Biotech and has held prior board roles at Escient, Aligos, Codexis, and Afferent.

Areas of interest